These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30724380)

  • 1. Enhanced antitumour activity of doxorubicin and simvastatin combination loaded nanoemulsion treatment against a Swiss albino mouse model of Ehrlich ascites carcinoma.
    Alkreathy HM; Alkhatib MH; Al Musaddi SA; Balamash KSA; Osman NN; Ahmad A
    Clin Exp Pharmacol Physiol; 2019 May; 46(5):496-505. PubMed ID: 30724380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QbD-based development of α-linolenic acid potentiated nanoemulsion for targeted delivery of doxorubicin in DMBA-induced mammary gland carcinoma: in vitro and in vivo evaluation.
    Tripathi CB; Parashar P; Arya M; Singh M; Kanoujia J; Kaithwas G; Saraf SA
    Drug Deliv Transl Res; 2018 Oct; 8(5):1313-1334. PubMed ID: 29748834
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Alkhatib MH; Alshehri WS; Abdu FB
    J Pharm Bioallied Sci; 2018; 10(1):35-42. PubMed ID: 29657506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activity against Ehrlich's ascites tumors of doxorubicin contained in self assembled, cell receptor targeted nanoparticle with simultaneous oral delivery of the green tea polyphenol epigallocatechin-3-gallate.
    Ray L; Kumar P; Gupta KC
    Biomaterials; 2013 Apr; 34(12):3064-76. PubMed ID: 23357370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sclareol is a potent enhancer of doxorubicin: Evaluation of the free combination and co-loaded nanostructured lipid carriers against breast cancer.
    Borges GSM; Silva JO; Fernandes RS; de Souza ÂM; Cassali GD; Yoshida MI; Leite EA; de Barros ALB; Ferreira LAM
    Life Sci; 2019 Sep; 232():116678. PubMed ID: 31344429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synergistic effect between vanillin and doxorubicin in ehrlich ascites carcinoma solid tumor and MCF-7 human breast cancer cell line.
    Elsherbiny NM; Younis NN; Shaheen MA; Elseweidy MM
    Pathol Res Pract; 2016 Sep; 212(9):767-77. PubMed ID: 27493101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antitumor effects of tetrodotoxin and/or doxorubicin on Ehrlich ascites carcinoma-bearing female mice.
    El-Dayem SM; Fouda FM; Ali EH; Motelp BA
    Toxicol Ind Health; 2013 Jun; 29(5):404-17. PubMed ID: 22317827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin Coadministration Modulates the Electrostatically Driven Incorporation of Doxorubicin into Model Lipid and Cell Membranes.
    Bartkowiak A; Nazaruk E; Gajda E; Godlewska M; Gaweł D; Jabłonowska E; Bilewicz R
    ACS Biomater Sci Eng; 2022 Oct; 8(10):4354-4364. PubMed ID: 36173110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Cremophor EL on the pharmacokinetics, antitumor activity and toxicity of doxorubicin in mice.
    Badary OA; Al-Shabanah OA; Al-Gharably NM; Elmazar MM
    Anticancer Drugs; 1998 Oct; 9(9):809-15. PubMed ID: 9840728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced anticancer effect and reduced toxicity of doxorubicin in combination with thymoquinone released from poly-N-acetyl glucosamine nanomatrix in mice bearing solid Ehrlish carcinoma.
    El-Ashmawy NE; Khedr EG; Ebeid EM; Salem ML; Zidan AA; Mosalam EM
    Eur J Pharm Sci; 2017 Nov; 109():525-532. PubMed ID: 28890201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron N-(2-hydroxy acetophenone) glycinate (FeNG), a non-toxic glutathione depletor circumvents doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo.
    Ganguly A; Chakraborty P; Banerjee K; Chatterjee S; Basu S; Sarkar A; Chatterjee M; Choudhuri SK
    Biometals; 2012 Feb; 25(1):149-63. PubMed ID: 21915630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect.
    Wiradharma N; Tong YW; Yang YY
    Biomaterials; 2009 Jun; 30(17):3100-9. PubMed ID: 19342093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vivo behavior and antitumor activity of doxorubicin-loaded poly(γ-benzyl l-glutamate)-block-hyaluronan polymersomes in Ehrlich ascites tumor-bearing BalB/c mice.
    Upadhyay KK; Mishra AK; Chuttani K; Kaul A; Schatz C; Le Meins JF; Misra A; Lecommandoux S
    Nanomedicine; 2012 Jan; 8(1):71-80. PubMed ID: 21703363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A liposomal formulation of simvastatin and doxorubicin for improved cardioprotective and anti-cancer effect.
    Bjørnstad R; Reiten IN; Knudsen KS; Schjøtt J; Herfindal L
    Int J Pharm; 2022 Dec; 629():122379. PubMed ID: 36370997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of L-histidinol on the antitumour activity and acute cardiotoxicity of doxorubicin in mice.
    Al-Shabanah OA; Badary OA; Al-Gharably NM; Al-Sawaf HA
    Pharmacol Res; 1998 Sep; 38(3):225-30. PubMed ID: 9782074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin loaded selenium nanoparticles synergize the anticancer potential of doxorubicin contained in self-assembled, cell receptor targeted nanoparticles.
    Kumari M; Purohit MP; Patnaik S; Shukla Y; Kumar P; Gupta KC
    Eur J Pharm Biopharm; 2018 Sep; 130():185-199. PubMed ID: 29969665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of a novel copper complex in overcoming doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo.
    Majumder S; Dutta P; Mookerjee A; Choudhuri SK
    Chem Biol Interact; 2006 Feb; 159(2):90-103. PubMed ID: 16289015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor Properties of Modified Detonation Nanodiamonds and Sorbed Doxorubicin on the Model of Ehrlich Ascites Carcinoma.
    Medvedeva NN; Zhukov EL; Inzhevatkin EV; Bezzabotnov VE
    Bull Exp Biol Med; 2016 Jan; 160(3):372-5. PubMed ID: 26742746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Combination Therapy with Linalool and Doxorubicin Encapsulated by Liposomes as a Two-in-One Hybrid Carrier System for Epithelial Ovarian Carcinoma.
    Wi TI; Won JE; Lee CM; Lee JW; Kang TH; Shin BC; Han HD; Park YM
    Int J Nanomedicine; 2020; 15():8427-8436. PubMed ID: 33149585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
    Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
    Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.